Physician profile
Bryan Haughom
NPI 1275828436
$178,738.35
in general payments reported to CMS, 2019-2025
13 companies · $85K in 2025
The $85K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,919 · 2020: $693 · 2021: $419 · 2022: $2,256 · 2023: $13K · 2024: $74K · 2025: $85K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $147K · Travel and Lodging: $21K · Food and Beverage: $3,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $147,058.83 |
| Travel and Lodging | $20,830.81 |
| Food and Beverage | $3,561.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $131,860.79 | 2022-2025 | Velys, Attune, Attune |
| Medacta USA, INC. | $23,183.58 | 2021-2025 | Gmk Sphere, Gmk Revision, M-Vizion |
| Depuy Synthes Products, INC. | $15,867.12 | 2024-2025 | Attune, Velys |
| Depuy Synthes Sales INC. | $3,184.89 | 2019-2025 | Attune |
| Stryker Corporation | $2,306.69 | 2019-2021 | |
| Microport Orthopedics INC | $1,928.00 | 2022 | |
| Aesculap Implant Systems, LLC | $229.03 | 2019-2021 | |
| Ethicon US, LLC | $60.69 | 2020-2023 | Ethicon, Stratafix |
| Bioventus LLC | $36.07 | 2019 | |
| Pacira Therapeutics, INC. | $24.04 | 2019 | |
| Avanos Medical | $22.72 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $20.04 | 2024 | Exparel |
| Aesculap Ag | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Haughom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.